Peter Yam-Kau Poon, Cheuk-Chun Szeto, Bonnie Ching-Ha Kwan, Kai-Ming Chow, Philip Kam-Tao Li
{"title":"Relationship between HSP70-2 A+1267G Polymorphism and Cardiovascular Events of Chinese Peritoneal Dialysis Patients.","authors":"Peter Yam-Kau Poon, Cheuk-Chun Szeto, Bonnie Ching-Ha Kwan, Kai-Ming Chow, Philip Kam-Tao Li","doi":"10.1159/000368237","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Heat shock proteins (HSPs) are expressed by cells in response to various environmental stresses. A single-nucleotide polymorphism A+1267G of the HSPA1B gene affects the expression of HSP70-2, with the A allele being protective against inflammatory conditions. We investigated the relation between the HSP A+1267G polymorphism and the clinical outcomes of Chinese peritoneal dialysis (PD) patients.</p><p><strong>Methods: </strong>We studied 347 new PD cases (181 males, age 56.6 ± 13.7 years). Genotyping was done by standard methods. Patients were followed for 40.5 ± 20.7 months for survival analysis.</p><p><strong>Results: </strong>For the entire cohort, there was no difference in the 5-year survival between genotype groups. However, there was a significant interaction between HSP polymorphism and diabetic status on the cardiovascular event-free survival. In patients without pre-existing diabetes, 5-year cardiovascular event-free survival of the GG/AG genotype group was significantly better than that of the AA genotype group (57.2 vs. 32.1%, p = 0.011).</p><p><strong>Conclusion: </strong>The G allele of the HSP70-2 A+1267G polymorphism confers survival advantages in non-diabetic PD patients. The role of HSP in the pathogenesis of cardiovascular disease in renal failure patients needs further investigation.</p>","PeriodicalId":19094,"journal":{"name":"Nephron Clinical Practice","volume":"128 1-2","pages":"153-8"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000368237","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephron Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000368237","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/11/20 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Heat shock proteins (HSPs) are expressed by cells in response to various environmental stresses. A single-nucleotide polymorphism A+1267G of the HSPA1B gene affects the expression of HSP70-2, with the A allele being protective against inflammatory conditions. We investigated the relation between the HSP A+1267G polymorphism and the clinical outcomes of Chinese peritoneal dialysis (PD) patients.
Methods: We studied 347 new PD cases (181 males, age 56.6 ± 13.7 years). Genotyping was done by standard methods. Patients were followed for 40.5 ± 20.7 months for survival analysis.
Results: For the entire cohort, there was no difference in the 5-year survival between genotype groups. However, there was a significant interaction between HSP polymorphism and diabetic status on the cardiovascular event-free survival. In patients without pre-existing diabetes, 5-year cardiovascular event-free survival of the GG/AG genotype group was significantly better than that of the AA genotype group (57.2 vs. 32.1%, p = 0.011).
Conclusion: The G allele of the HSP70-2 A+1267G polymorphism confers survival advantages in non-diabetic PD patients. The role of HSP in the pathogenesis of cardiovascular disease in renal failure patients needs further investigation.
背景:热休克蛋白(HSPs)是细胞对各种环境应激的反应。HSPA1B基因的单核苷酸多态性A+1267G影响HSP70-2的表达,其中A等位基因对炎症具有保护作用。我们研究了HSP A+1267G多态性与中国腹膜透析(PD)患者临床结局的关系。方法:对347例PD新发病例进行分析,其中男性181例,年龄56.6±13.7岁。采用标准方法进行基因分型。随访40.5±20.7个月进行生存分析。结果:在整个队列中,基因型组之间的5年生存率没有差异。然而,HSP多态性与糖尿病状态对无心血管事件生存有显著的相互作用。在无糖尿病患者中,GG/AG基因型组的5年无心血管事件生存率显著优于AA基因型组(57.2 vs. 32.1%, p = 0.011)。结论:HSP70-2 A+1267G多态性的G等位基因在非糖尿病性PD患者中具有生存优势。热休克蛋白在肾衰竭患者心血管疾病发病机制中的作用有待进一步研究。